MTZPY - Mitsubishi Tanabe Pharma Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/3/2019
30/3/2018
30/3/2017
30/3/2016
Total revenue
38,97,02,000
42,47,67,000
43,38,55,000
42,39,77,000
43,17,03,000
Cost of revenue
18,45,10,000
18,06,46,000
16,97,50,000
16,43,97,000
15,58,08,000
Gross profit
20,51,92,000
24,41,21,000
26,41,05,000
25,95,80,000
27,58,95,000
Operating expenses
Research development
8,21,81,000
8,65,33,000
7,90,83,000
6,47,83,000
7,52,93,000
Selling general and administrative
9,68,23,000
9,87,25,000
10,40,55,000
9,83,02,000
1,15,94,000
Total operating expenses
18,63,51,000
19,37,38,000
18,68,43,000
16,55,21,000
18,09,88,000
Operating income or loss
1,88,41,000
5,03,83,000
7,72,62,000
9,40,59,000
9,49,07,000
Interest expense
-
-
-
-
2,02,000
Income before tax
1,84,79,000
5,04,39,000
7,87,64,000
9,60,59,000
8,43,12,000
Income tax expense
89,65,000
1,82,23,000
2,47,72,000
2,71,37,000
3,01,55,000
Income from continuing operations
95,14,000
3,22,16,000
5,39,92,000
6,89,22,000
5,41,57,000
Net income
1,41,27,000
3,73,72,000
5,79,63,000
7,12,63,000
5,64,34,000
Net income available to common shareholders
1,41,27,000
3,73,72,000
5,79,63,000
7,12,63,000
5,64,34,000
EBITDA
-
6,19,12,000
8,87,97,000
10,45,13,000
10,38,50,000